Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis

Kaushik Mukherjee, Dunfa Peng, Zaid Brifkani, Abbes Belkhiri, Manuel Pera, Tatsuki Koyama, Elizabeth A.S. Koehler, Frank L. Revetta, Mary K. Washington, Wael El-Rifai

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Gastric adenocarcinoma is a leading cause of cancer mortality. The role of dopamine and cAMP regulated phosphoprotein MW 32 kDa (DARPP-32) overexpression in the gastric tumorigenesis cascade remains unclear. Methods: The expression of DARPP-32 in the multistep carcinogenesis cascade was examined using immunohistochemistry analysis on 533 samples. The contribution of DARPP-32 in cellular transformation and molecular signaling was investigated using NIH3T3, AGS, and SNU16 cells. Results: The composite expression score (CES), calculated from immunostaining patterns, increased significantly from normal or gastritis to metaplasia, dysplasia, and adenocarcinoma (P < .001). In patients with normal stomach or gastritis and tumor samples, a 76% and 77% chance, respectively, was found (P < .001) that CES was higher in the tumor. High median CES correlated with well- or moderately differentiated (P = .03) gastric adenocarcinomas. NIH3T3 cells transfected with DARPP-32 demonstrated increased levels of phospho-AKT and a 5-fold increase in the number of foci as compared with the control (P = .02). DARPP-32 expression in AGS cells led to increased protein levels of phospho-AKT and BCL-2. For validation, the knockdown of endogenous DARPP-32 expression in SNU16 cells using shRNA resulted in decreased levels of phospho-AKT phosphorylation and BCL-2. Conclusion: Our results suggest that DARPP-32 overexpression may participate in the transition to intestinal metaplasia and in the progression to neoplasia. The ability of DARPP-32 to transform NIH3T3 cells and to regulate AKT and BCL-2 underscores its possible oncogenic potential.

Original languageEnglish (US)
Pages (from-to)354-363
Number of pages10
JournalSurgery
Volume148
Issue number2
DOIs
StatePublished - Jun 25 2010
Externally publishedYes

Fingerprint

Dopamine and cAMP-Regulated Phosphoprotein 32
Stomach
Carcinogenesis
Adenocarcinoma
Metaplasia
Gastritis
Neoplasms
Small Interfering RNA
Immunohistochemistry
Phosphorylation

ASJC Scopus subject areas

  • Surgery

Cite this

Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis. / Mukherjee, Kaushik; Peng, Dunfa; Brifkani, Zaid; Belkhiri, Abbes; Pera, Manuel; Koyama, Tatsuki; Koehler, Elizabeth A.S.; Revetta, Frank L.; Washington, Mary K.; El-Rifai, Wael.

In: Surgery, Vol. 148, No. 2, 25.06.2010, p. 354-363.

Research output: Contribution to journalArticle

Mukherjee, K, Peng, D, Brifkani, Z, Belkhiri, A, Pera, M, Koyama, T, Koehler, EAS, Revetta, FL, Washington, MK & El-Rifai, W 2010, 'Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis', Surgery, vol. 148, no. 2, pp. 354-363. https://doi.org/10.1016/j.surg.2010.05.011
Mukherjee, Kaushik ; Peng, Dunfa ; Brifkani, Zaid ; Belkhiri, Abbes ; Pera, Manuel ; Koyama, Tatsuki ; Koehler, Elizabeth A.S. ; Revetta, Frank L. ; Washington, Mary K. ; El-Rifai, Wael. / Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis. In: Surgery. 2010 ; Vol. 148, No. 2. pp. 354-363.
@article{340029529bda4b8a991823932293ddb2,
title = "Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis",
abstract = "Background: Gastric adenocarcinoma is a leading cause of cancer mortality. The role of dopamine and cAMP regulated phosphoprotein MW 32 kDa (DARPP-32) overexpression in the gastric tumorigenesis cascade remains unclear. Methods: The expression of DARPP-32 in the multistep carcinogenesis cascade was examined using immunohistochemistry analysis on 533 samples. The contribution of DARPP-32 in cellular transformation and molecular signaling was investigated using NIH3T3, AGS, and SNU16 cells. Results: The composite expression score (CES), calculated from immunostaining patterns, increased significantly from normal or gastritis to metaplasia, dysplasia, and adenocarcinoma (P < .001). In patients with normal stomach or gastritis and tumor samples, a 76{\%} and 77{\%} chance, respectively, was found (P < .001) that CES was higher in the tumor. High median CES correlated with well- or moderately differentiated (P = .03) gastric adenocarcinomas. NIH3T3 cells transfected with DARPP-32 demonstrated increased levels of phospho-AKT and a 5-fold increase in the number of foci as compared with the control (P = .02). DARPP-32 expression in AGS cells led to increased protein levels of phospho-AKT and BCL-2. For validation, the knockdown of endogenous DARPP-32 expression in SNU16 cells using shRNA resulted in decreased levels of phospho-AKT phosphorylation and BCL-2. Conclusion: Our results suggest that DARPP-32 overexpression may participate in the transition to intestinal metaplasia and in the progression to neoplasia. The ability of DARPP-32 to transform NIH3T3 cells and to regulate AKT and BCL-2 underscores its possible oncogenic potential.",
author = "Kaushik Mukherjee and Dunfa Peng and Zaid Brifkani and Abbes Belkhiri and Manuel Pera and Tatsuki Koyama and Koehler, {Elizabeth A.S.} and Revetta, {Frank L.} and Washington, {Mary K.} and Wael El-Rifai",
year = "2010",
month = "6",
day = "25",
doi = "10.1016/j.surg.2010.05.011",
language = "English (US)",
volume = "148",
pages = "354--363",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis

AU - Mukherjee, Kaushik

AU - Peng, Dunfa

AU - Brifkani, Zaid

AU - Belkhiri, Abbes

AU - Pera, Manuel

AU - Koyama, Tatsuki

AU - Koehler, Elizabeth A.S.

AU - Revetta, Frank L.

AU - Washington, Mary K.

AU - El-Rifai, Wael

PY - 2010/6/25

Y1 - 2010/6/25

N2 - Background: Gastric adenocarcinoma is a leading cause of cancer mortality. The role of dopamine and cAMP regulated phosphoprotein MW 32 kDa (DARPP-32) overexpression in the gastric tumorigenesis cascade remains unclear. Methods: The expression of DARPP-32 in the multistep carcinogenesis cascade was examined using immunohistochemistry analysis on 533 samples. The contribution of DARPP-32 in cellular transformation and molecular signaling was investigated using NIH3T3, AGS, and SNU16 cells. Results: The composite expression score (CES), calculated from immunostaining patterns, increased significantly from normal or gastritis to metaplasia, dysplasia, and adenocarcinoma (P < .001). In patients with normal stomach or gastritis and tumor samples, a 76% and 77% chance, respectively, was found (P < .001) that CES was higher in the tumor. High median CES correlated with well- or moderately differentiated (P = .03) gastric adenocarcinomas. NIH3T3 cells transfected with DARPP-32 demonstrated increased levels of phospho-AKT and a 5-fold increase in the number of foci as compared with the control (P = .02). DARPP-32 expression in AGS cells led to increased protein levels of phospho-AKT and BCL-2. For validation, the knockdown of endogenous DARPP-32 expression in SNU16 cells using shRNA resulted in decreased levels of phospho-AKT phosphorylation and BCL-2. Conclusion: Our results suggest that DARPP-32 overexpression may participate in the transition to intestinal metaplasia and in the progression to neoplasia. The ability of DARPP-32 to transform NIH3T3 cells and to regulate AKT and BCL-2 underscores its possible oncogenic potential.

AB - Background: Gastric adenocarcinoma is a leading cause of cancer mortality. The role of dopamine and cAMP regulated phosphoprotein MW 32 kDa (DARPP-32) overexpression in the gastric tumorigenesis cascade remains unclear. Methods: The expression of DARPP-32 in the multistep carcinogenesis cascade was examined using immunohistochemistry analysis on 533 samples. The contribution of DARPP-32 in cellular transformation and molecular signaling was investigated using NIH3T3, AGS, and SNU16 cells. Results: The composite expression score (CES), calculated from immunostaining patterns, increased significantly from normal or gastritis to metaplasia, dysplasia, and adenocarcinoma (P < .001). In patients with normal stomach or gastritis and tumor samples, a 76% and 77% chance, respectively, was found (P < .001) that CES was higher in the tumor. High median CES correlated with well- or moderately differentiated (P = .03) gastric adenocarcinomas. NIH3T3 cells transfected with DARPP-32 demonstrated increased levels of phospho-AKT and a 5-fold increase in the number of foci as compared with the control (P = .02). DARPP-32 expression in AGS cells led to increased protein levels of phospho-AKT and BCL-2. For validation, the knockdown of endogenous DARPP-32 expression in SNU16 cells using shRNA resulted in decreased levels of phospho-AKT phosphorylation and BCL-2. Conclusion: Our results suggest that DARPP-32 overexpression may participate in the transition to intestinal metaplasia and in the progression to neoplasia. The ability of DARPP-32 to transform NIH3T3 cells and to regulate AKT and BCL-2 underscores its possible oncogenic potential.

UR - http://www.scopus.com/inward/record.url?scp=77955299406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955299406&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2010.05.011

DO - 10.1016/j.surg.2010.05.011

M3 - Article

C2 - 20580047

AN - SCOPUS:77955299406

VL - 148

SP - 354

EP - 363

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 2

ER -